Annual Secretarial Compliance Report for the year ended March 31, 2025
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr Reddy's Laboratories has filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2025, as required under SEBI Regulation 24A. The report was certified by Makarand M. Joshi & Co., Practicing Company Secretaries, after examining all relevant filings, records, and submissions. The company is fully compliant across all checked areas, including SEBI Listing Regulations, Insider Trading norms, Secretarial Standards issued by ICSI, and disclosures on its website. No deviations, penalties, or regulatory actions by SEBI or stock exchanges were reported during the review period. There were no resignations of statutory auditors and no additional non-compliances observed.
This is a routine regulatory filing that confirms strong corporate governance and full compliance with SEBI regulations. It is mildly positive for shareholders as it shows no penalties, no regulatory actions, and no governance issues — reinforcing investor confidence in the company's compliance standards.